Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
172
NCT03162094
Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome
Phase: Phase 1/2
Role: Lead Sponsor
Start: Apr 3, 2017
Completion: Dec 31, 2018